stockrowCytokinetics, Incorporated (CYTK) vs Krystal Biotech, Inc. (KRYS)
- Cytokinetics, Incorporated CYTK 54.83 −1.30%
- Krystal Biotech, Inc. KRYS 302.62 +0.79%
Cytokinetics, Incorporated and Krystal Biotech, Inc. are both Biotechnology companies. Krystal Biotech, Inc. is the larger, with a market value of $8.9B against $7.7B — 1.2× the size. Cytokinetics, Incorporated has negative trailing earnings, so its P/E is not meaningful; Krystal Biotech, Inc. trades at 39.2×. Cytokinetics, Incorporated grew revenue faster over the last twelve months: 29.9% against 26.0%. Krystal Biotech, Inc. has the higher net margin (47.9% vs −686.6%) and the higher return on invested capital (27.2% vs 0.00%). Across the 16 metrics below, Krystal Biotech, Inc. leads on 13 and Cytokinetics, Incorporated on 3.
Valuation
Profitability
| Metric | CYTK | KRYS | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 94.27% | 65.16% |
| Operating margin | (625.15%) | 48.41% | 0.00% |
| Net margin | (686.63%) | 47.91% | 0.00% |
| Free cash flow margin | (519.53%) | 65.97% | 0.00% |
| Return on equity | 184.71% | 17.50% | (50.12%) |
| Return on assets | (47.70%) | 15.93% | (45.60%) |
| Return on invested capital | 0.00% | 27.15% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack